 Jayne Martin Carli
Concepts (135)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mammary Glands, Human | 2 | 2021 | 60 | 1.430 |
Why?
| | Lactation | 2 | 2021 | 149 | 1.370 |
Why?
| | Milk, Human | 2 | 2021 | 127 | 1.340 |
Why?
| | Adipogenesis | 2 | 2018 | 42 | 0.890 |
Why?
| | Single-Cell Analysis | 2 | 2021 | 188 | 0.820 |
Why?
| | Adipocytes | 2 | 2018 | 188 | 0.810 |
Why?
| | Computational Biology | 2 | 2021 | 530 | 0.690 |
Why?
| | Alpha-Ketoglutarate-Dependent Dioxygenase FTO | 2 | 2018 | 22 | 0.640 |
Why?
| | Sequence Analysis, RNA | 1 | 2021 | 385 | 0.640 |
Why?
| | Epithelial Cells | 2 | 2021 | 951 | 0.620 |
Why?
| | Diabetes, Gestational | 1 | 2020 | 281 | 0.540 |
Why?
| | Adenosine | 1 | 2018 | 203 | 0.540 |
Why?
| | Lipid Metabolism | 1 | 2018 | 444 | 0.490 |
Why?
| | Adiposity | 3 | 2020 | 458 | 0.430 |
Why?
| | Interleukin-2 | 2 | 2011 | 413 | 0.400 |
Why?
| | DNA | 1 | 2018 | 1352 | 0.380 |
Why?
| | CD56 Antigen | 2 | 2013 | 34 | 0.380 |
Why?
| | Interleukin-2 Receptor alpha Subunit | 2 | 2011 | 66 | 0.370 |
Why?
| | Adaptor Proteins, Signal Transducing | 2 | 2018 | 367 | 0.340 |
Why?
| | Killer Cells, Natural | 2 | 2013 | 380 | 0.310 |
Why?
| | Leptin | 3 | 2020 | 210 | 0.300 |
Why?
| | Prader-Willi Syndrome | 2 | 2017 | 25 | 0.280 |
Why?
| | T-Lymphocytes | 2 | 2011 | 1737 | 0.260 |
Why?
| | Neurons | 3 | 2017 | 1280 | 0.230 |
Why?
| | Immunoglobulin G | 3 | 2013 | 770 | 0.210 |
Why?
| | Flow Cytometry | 2 | 2020 | 1083 | 0.210 |
Why?
| | RNA, Small Nucleolar | 2 | 2017 | 8 | 0.180 |
Why?
| | Gene Knockdown Techniques | 2 | 2018 | 299 | 0.170 |
Why?
| | Immunosuppressive Agents | 3 | 2013 | 646 | 0.160 |
Why?
| | Antibodies, Monoclonal, Humanized | 3 | 2013 | 663 | 0.160 |
Why?
| | Receptor-Like Protein Tyrosine Phosphatases, Class 3 | 1 | 2018 | 3 | 0.160 |
Why?
| | 3T3-L1 Cells | 1 | 2018 | 31 | 0.150 |
Why?
| | Postpartum Period | 1 | 2020 | 278 | 0.150 |
Why?
| | Extracellular Matrix Proteins | 1 | 2018 | 127 | 0.140 |
Why?
| | Hypothalamus | 2 | 2015 | 147 | 0.140 |
Why?
| | Proprotein Convertase 1 | 1 | 2016 | 3 | 0.140 |
Why?
| | Growth Hormone-Releasing Hormone | 1 | 2016 | 26 | 0.140 |
Why?
| | Proinsulin | 1 | 2016 | 48 | 0.140 |
Why?
| | Stem Cells | 1 | 2020 | 546 | 0.130 |
Why?
| | Induced Pluripotent Stem Cells | 2 | 2016 | 182 | 0.130 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2018 | 398 | 0.130 |
Why?
| | Protein Precursors | 1 | 2016 | 119 | 0.130 |
Why?
| | Research Design | 1 | 2021 | 928 | 0.120 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2020 | 1214 | 0.120 |
Why?
| | Neoplasm Proteins | 1 | 2018 | 385 | 0.120 |
Why?
| | Antibodies, Monoclonal | 2 | 2011 | 1262 | 0.120 |
Why?
| | Mice | 6 | 2018 | 14869 | 0.110 |
Why?
| | DNA Methylation | 1 | 2018 | 495 | 0.110 |
Why?
| | Phosphorylation | 1 | 2018 | 1569 | 0.110 |
Why?
| | Signal Transduction | 3 | 2018 | 4513 | 0.110 |
Why?
| | Vasculitis, Central Nervous System | 1 | 2013 | 17 | 0.110 |
Why?
| | Cilia | 1 | 2014 | 162 | 0.100 |
Why?
| | Islets of Langerhans | 1 | 2017 | 726 | 0.100 |
Why?
| | Adipose Tissue | 2 | 2016 | 545 | 0.090 |
Why?
| | Polymorphism, Genetic | 1 | 2014 | 610 | 0.090 |
Why?
| | Multiple Sclerosis | 2 | 2013 | 376 | 0.090 |
Why?
| | Lewis X Antigen | 1 | 2010 | 4 | 0.090 |
Why?
| | Lipolysis | 1 | 2010 | 39 | 0.090 |
Why?
| | Interleukin-7 Receptor alpha Subunit | 1 | 2010 | 11 | 0.090 |
Why?
| | K562 Cells | 1 | 2010 | 73 | 0.090 |
Why?
| | Animals | 7 | 2018 | 31706 | 0.090 |
Why?
| | Interleukin-7 | 1 | 2010 | 45 | 0.090 |
Why?
| | Antigen Presentation | 1 | 2011 | 188 | 0.090 |
Why?
| | Cells, Cultured | 3 | 2015 | 3886 | 0.090 |
Why?
| | Mice, Inbred C57BL | 4 | 2018 | 4694 | 0.080 |
Why?
| | Cytotoxicity, Immunologic | 1 | 2010 | 195 | 0.080 |
Why?
| | Genome-Wide Association Study | 1 | 2016 | 1177 | 0.080 |
Why?
| | Forkhead Transcription Factors | 1 | 2010 | 170 | 0.080 |
Why?
| | Female | 6 | 2021 | 59507 | 0.080 |
Why?
| | Pregnancy | 1 | 2020 | 5518 | 0.080 |
Why?
| | Proteins | 1 | 2014 | 908 | 0.080 |
Why?
| | Dendritic Cells | 1 | 2011 | 435 | 0.070 |
Why?
| | 3T3 Cells | 1 | 2018 | 140 | 0.070 |
Why?
| | Cell Differentiation | 1 | 2015 | 1701 | 0.070 |
Why?
| | Leukocytes, Mononuclear | 1 | 2010 | 493 | 0.070 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2010 | 339 | 0.070 |
Why?
| | Humans | 9 | 2021 | 114686 | 0.070 |
Why?
| | Gene Expression Regulation | 1 | 2016 | 2320 | 0.070 |
Why?
| | Diet, High-Fat | 1 | 2018 | 225 | 0.070 |
Why?
| | Obesity | 2 | 2016 | 2508 | 0.070 |
Why?
| | Weight Loss | 1 | 2010 | 642 | 0.060 |
Why?
| | Cell Line | 1 | 2010 | 2637 | 0.060 |
Why?
| | Cell Proliferation | 1 | 2010 | 2187 | 0.050 |
Why?
| | Adult | 1 | 2020 | 30550 | 0.040 |
Why?
| | Transcription Factors | 2 | 2017 | 1528 | 0.040 |
Why?
| | Prosencephalon | 1 | 2017 | 45 | 0.040 |
Why?
| | Protein Conformation | 1 | 2020 | 805 | 0.040 |
Why?
| | Sequence Deletion | 1 | 2017 | 167 | 0.040 |
Why?
| | Multigene Family | 1 | 2017 | 190 | 0.030 |
Why?
| | Hyperphagia | 1 | 2016 | 28 | 0.030 |
Why?
| | Hypogonadism | 1 | 2016 | 75 | 0.030 |
Why?
| | Cerebellum | 1 | 2017 | 200 | 0.030 |
Why?
| | Tissue Culture Techniques | 1 | 2016 | 66 | 0.030 |
Why?
| | Models, Molecular | 1 | 2020 | 1369 | 0.030 |
Why?
| | Genetic Variation | 1 | 2020 | 870 | 0.030 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2020 | 801 | 0.030 |
Why?
| | Genotype | 1 | 2020 | 1760 | 0.030 |
Why?
| | Pro-Opiomelanocortin | 1 | 2015 | 17 | 0.030 |
Why?
| | Thyroid Nuclear Factor 1 | 1 | 2015 | 14 | 0.030 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 1 | 2016 | 225 | 0.030 |
Why?
| | Antigens, Differentiation | 1 | 2015 | 79 | 0.030 |
Why?
| | Receptors, Leptin | 1 | 2014 | 24 | 0.030 |
Why?
| | Embryonic Stem Cells | 1 | 2015 | 106 | 0.030 |
Why?
| | Homeodomain Proteins | 1 | 2017 | 463 | 0.030 |
Why?
| | Brain-Derived Neurotrophic Factor | 1 | 2015 | 106 | 0.030 |
Why?
| | Hedgehog Proteins | 1 | 2015 | 172 | 0.030 |
Why?
| | Introns | 1 | 2014 | 227 | 0.030 |
Why?
| | Male | 5 | 2017 | 55596 | 0.030 |
Why?
| | STAT3 Transcription Factor | 1 | 2014 | 173 | 0.030 |
Why?
| | Methylprednisolone | 1 | 2013 | 81 | 0.030 |
Why?
| | Cyclophosphamide | 1 | 2013 | 217 | 0.030 |
Why?
| | Eating | 1 | 2014 | 344 | 0.020 |
Why?
| | Interleukin-2 Receptor beta Subunit | 1 | 2011 | 19 | 0.020 |
Why?
| | Transplantation Tolerance | 1 | 2011 | 30 | 0.020 |
Why?
| | Disability Evaluation | 1 | 2013 | 271 | 0.020 |
Why?
| | Models, Immunological | 1 | 2011 | 92 | 0.020 |
Why?
| | Weight Gain | 1 | 2014 | 453 | 0.020 |
Why?
| | Carboxylic Ester Hydrolases | 1 | 2010 | 15 | 0.020 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 797 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2016 | 2570 | 0.020 |
Why?
| | Nuclear Proteins | 1 | 2015 | 591 | 0.020 |
Why?
| | Lipase | 1 | 2010 | 55 | 0.020 |
Why?
| | Phenotype | 1 | 2017 | 2796 | 0.020 |
Why?
| | Fatty Acids, Nonesterified | 1 | 2010 | 151 | 0.020 |
Why?
| | Fibroblasts | 1 | 2014 | 838 | 0.020 |
Why?
| | Anti-Inflammatory Agents | 1 | 2013 | 447 | 0.020 |
Why?
| | In Vitro Techniques | 1 | 2011 | 1016 | 0.020 |
Why?
| | Diabetes Mellitus | 1 | 2016 | 900 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2016 | 2553 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2017 | 3535 | 0.020 |
Why?
| | Lymphocyte Activation | 1 | 2011 | 1037 | 0.020 |
Why?
| | Cell Movement | 1 | 2010 | 869 | 0.020 |
Why?
| | Brain | 1 | 2017 | 2371 | 0.020 |
Why?
| | Macrophages | 1 | 2010 | 1263 | 0.010 |
Why?
| | Magnetic Resonance Imaging | 1 | 2013 | 3052 | 0.010 |
Why?
|
|
Martin Carli's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|